(Q41741997)

English

A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer

scientific article published on 12 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

Alexander Stein

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Karsten Ridwelski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Djordje Atanackovic

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ewald Wöll

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Alexis Ulrich

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Ramona Fischer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Colin Krüger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christoph Schuhmacher

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

833-842

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Present and future status of gastric cancer surgery

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

New criteria for ventilation-perfusion lung scan interpretation: a basis for optimal interaction with helical CT angiography.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Incidence and risk factors for hospital-acquired pneumonia after surgery for gastric cancer: results of prospective surveillance

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0423-6

21 January 2018

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence following curative resection for gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25214034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-014-0423-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25214034%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41741997&oldid=2204752182"